SEC 13F Intelligence

North Growth Management Ltd. / ELV

North Growth Management Ltd.’s Elevance Health Inc Formerly Position

Does North Growth Management Ltd. own Elevance Health Inc Formerly (ELV)? Yes — 26.0K shares worth $8M (+1.16% of its 13F portfolio) as of Q1 2026, up from 22.0K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
26.0K
% of Portfolio
+1.16%
Quarters Held
29
currently held

Position History ELV

Reported value by quarter
Q1 ’19: $6MQ1 ’19Q2 ’19: $6MQ3 ’19: $7MQ4 ’19: $9MQ1 ’20: $8MQ1 ’20Q2 ’20: $9MQ3 ’20: $11MQ4 ’20: $12MQ1 ’21: $14MQ1 ’21Q2 ’21: $15MQ3 ’21: $15MQ4 ’21: $18MQ1 ’22: $19MQ1 ’22Q2 ’22: $15MQ3 ’22: $15MQ4 ’22: $16MQ1 ’23: $13MQ1 ’23Q2 ’23: $13MQ3 ’23: $12MQ4 ’23: $13MQ1 ’24: $15MQ1 ’24Q2 ’24: $15MQ3 ’24: $15MQ4 ’24: $10MQ1 ’25: $12MQ1 ’25Q2 ’25: $9MQ3 ’25: $7MQ4 ’25: $8MQ1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202626.0K$8M+1.16%
Q4 202522.0K$8M+1.22%
Q3 202522.0K$7M+1.24%
Q2 202522.0K$9M+1.62%
Q1 202528.0K$12M+2.55%
Q4 202428.0K$10M+1.94%
Q3 202428.0K$15M+2.73%
Q2 202428.0K$15M+3.00%
Q1 202428.0K$15M+2.77%
Q4 202328.0K$13M+2.84%
Q3 202328.0K$12M+2.73%
Q2 202329.0K$13M+2.63%
Q1 202329.0K$13M+2.83%
Q4 202232.0K$16M+3.72%
Q3 202232.0K$15M+3.62%
Q2 202232.0K$15M+3.57%
Q1 202239.0K$19M+3.57%
Q4 202139.0K$18M+3.02%
Q3 202139.0K$15M+2.57%
Q2 202139.0K$15M+2.42%
Q1 202139.0K$14M+2.47%
Q4 202039.0K$12M+2.56%
Q3 202042.0K$11M+2.47%
Q2 202033.0K$9M+2.08%
Q1 202034.0K$8M+2.16%
Q4 201930.0K$9M+2.06%
Q3 201930.0K$7M+1.76%
Q2 201922.0K$6M+1.52%
Q1 201922.0K$6M+1.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See North Growth Management Ltd.’s full portfolio or all institutional holders of ELV.